Partial thromboplastin time as a screening test

John A Robbins, S. D. Rose

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The partial thromboplastin time was first described by Langdell, Wagner, and Brinkhous in 1953 and has been shown to be a useful screening test in the detection of latent bleeding disorders and minor clotting-factor deficiencies. To our knowledge, no one has questioned its routine application to medical and surgical preoperative patients. It is well documented that the partial thromboplastin time is an effective test when used to screen patients with a previous history of bleeding abnormalities. We found that all the patients with prolonged partial thromboplastin times had a predictable risk for a bleeding abnormality at the time of the partial thromboplastin time measurement. One can conclude from our data with screening partial thromboplastin times that the abnormal test results were found in patients who have a clinically predictable bleeding risk.

Original languageEnglish (US)
Pages (from-to)796-797
Number of pages2
JournalAnnals of Internal Medicine
Volume90
Issue number5
StatePublished - 1979

Fingerprint

Partial Thromboplastin Time
Hemorrhage
Blood Coagulation Factors

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Partial thromboplastin time as a screening test. / Robbins, John A; Rose, S. D.

In: Annals of Internal Medicine, Vol. 90, No. 5, 1979, p. 796-797.

Research output: Contribution to journalArticle

Robbins, John A ; Rose, S. D. / Partial thromboplastin time as a screening test. In: Annals of Internal Medicine. 1979 ; Vol. 90, No. 5. pp. 796-797.
@article{9835a526cc624531a8d398bf3568e0dc,
title = "Partial thromboplastin time as a screening test",
abstract = "The partial thromboplastin time was first described by Langdell, Wagner, and Brinkhous in 1953 and has been shown to be a useful screening test in the detection of latent bleeding disorders and minor clotting-factor deficiencies. To our knowledge, no one has questioned its routine application to medical and surgical preoperative patients. It is well documented that the partial thromboplastin time is an effective test when used to screen patients with a previous history of bleeding abnormalities. We found that all the patients with prolonged partial thromboplastin times had a predictable risk for a bleeding abnormality at the time of the partial thromboplastin time measurement. One can conclude from our data with screening partial thromboplastin times that the abnormal test results were found in patients who have a clinically predictable bleeding risk.",
author = "Robbins, {John A} and Rose, {S. D.}",
year = "1979",
language = "English (US)",
volume = "90",
pages = "796--797",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Partial thromboplastin time as a screening test

AU - Robbins, John A

AU - Rose, S. D.

PY - 1979

Y1 - 1979

N2 - The partial thromboplastin time was first described by Langdell, Wagner, and Brinkhous in 1953 and has been shown to be a useful screening test in the detection of latent bleeding disorders and minor clotting-factor deficiencies. To our knowledge, no one has questioned its routine application to medical and surgical preoperative patients. It is well documented that the partial thromboplastin time is an effective test when used to screen patients with a previous history of bleeding abnormalities. We found that all the patients with prolonged partial thromboplastin times had a predictable risk for a bleeding abnormality at the time of the partial thromboplastin time measurement. One can conclude from our data with screening partial thromboplastin times that the abnormal test results were found in patients who have a clinically predictable bleeding risk.

AB - The partial thromboplastin time was first described by Langdell, Wagner, and Brinkhous in 1953 and has been shown to be a useful screening test in the detection of latent bleeding disorders and minor clotting-factor deficiencies. To our knowledge, no one has questioned its routine application to medical and surgical preoperative patients. It is well documented that the partial thromboplastin time is an effective test when used to screen patients with a previous history of bleeding abnormalities. We found that all the patients with prolonged partial thromboplastin times had a predictable risk for a bleeding abnormality at the time of the partial thromboplastin time measurement. One can conclude from our data with screening partial thromboplastin times that the abnormal test results were found in patients who have a clinically predictable bleeding risk.

UR - http://www.scopus.com/inward/record.url?scp=0018744777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018744777&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 796

EP - 797

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -